Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Imaging Essential Tremor

Identifieur interne : 000B64 ( PascalFrancis/Corpus ); précédent : 000B63; suivant : 000B65

Imaging Essential Tremor

Auteurs : Ioannis U. Isaias ; Giorgio Marotta ; Shigeki Hirano ; Margherita Canesi ; Riccardo Benti ; Andrea Righini ; CHENGKE TANG ; Roberto Cilia ; Gianni Pezzoli ; David Eidelberg ; Angelo Antonini

Source :

RBID : Pascal:10-0233093

Descripteurs français

English descriptors

Abstract

To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akineticrigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 25
A06       @2 6
A08 01  1  ENG  @1 Imaging Essential Tremor
A11 01  1    @1 ISAIAS (Ioannis U.)
A11 02  1    @1 MAROTTA (Giorgio)
A11 03  1    @1 HIRANO (Shigeki)
A11 04  1    @1 CANESI (Margherita)
A11 05  1    @1 BENTI (Riccardo)
A11 06  1    @1 RIGHINI (Andrea)
A11 07  1    @1 CHENGKE TANG
A11 08  1    @1 CILIA (Roberto)
A11 09  1    @1 PEZZOLI (Gianni)
A11 10  1    @1 EIDELBERG (David)
A11 11  1    @1 ANTONINI (Angelo)
A14 01      @1 Department of Human Physiology, University of Milano @2 Milano @3 ITA @Z 1 aut.
A14 02      @1 Parkinson Institute, Istituti Clinici di Perfezionamento @2 Milano @3 ITA @Z 1 aut. @Z 4 aut. @Z 8 aut. @Z 9 aut. @Z 11 aut.
A14 03      @1 Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico @2 Milano @3 ITA @Z 2 aut. @Z 5 aut.
A14 04      @1 Center for Neurosciences, The Feinstein Institute for Medical Research @2 Manhasset, New York @3 USA @Z 3 aut. @Z 7 aut. @Z 10 aut.
A14 05      @1 Neuroradiology Department, V. Buzzi Hospital @2 Milano @3 ITA @Z 6 aut.
A14 06      @1 Departments of Neurology and Medicine, North Shore University Hospital, North Shore-LIJ Health System @2 Manhasset, New York @3 USA @Z 10 aut.
A14 07      @1 Institute of Neurology, IRCCS San Camillo, Venice and University of Padua @3 ITA @Z 11 aut.
A20       @1 679-686
A21       @1 2010
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000181078480030
A44       @0 0000 @1 © 2010 INIST-CNRS. All rights reserved.
A45       @0 44 ref.
A47 01  1    @0 10-0233093
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akineticrigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.
C02 01  X    @0 002B17
C02 02  X    @0 002B24A06
C03 01  X  FRE  @0 Tremblement @5 01
C03 01  X  ENG  @0 Tremor @5 01
C03 01  X  SPA  @0 Temblor @5 01
C03 02  X  FRE  @0 Pathologie du système nerveux @5 02
C03 02  X  ENG  @0 Nervous system diseases @5 02
C03 02  X  SPA  @0 Sistema nervioso patología @5 02
C03 03  X  FRE  @0 Tomoscintigraphie émission monophotonique @5 09
C03 03  X  ENG  @0 Single photon emission tomography @5 09
C03 03  X  SPA  @0 Tomografía emisión fotón único @5 09
C03 04  X  FRE  @0 Photon @5 10
C03 04  X  ENG  @0 Photon @5 10
C03 04  X  SPA  @0 Fotón @5 10
C07 01  X  FRE  @0 Mouvement involontaire @5 37
C07 01  X  ENG  @0 Involuntary movement @5 37
C07 01  X  SPA  @0 Movimiento involuntario @5 37
C07 02  X  FRE  @0 Trouble neurologique @5 39
C07 02  X  ENG  @0 Neurological disorder @5 39
C07 02  X  SPA  @0 Trastorno neurológico @5 39
N21       @1 158
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 10-0233093 INIST
ET : Imaging Essential Tremor
AU : ISAIAS (Ioannis U.); MAROTTA (Giorgio); HIRANO (Shigeki); CANESI (Margherita); BENTI (Riccardo); RIGHINI (Andrea); CHENGKE TANG; CILIA (Roberto); PEZZOLI (Gianni); EIDELBERG (David); ANTONINI (Angelo)
AF : Department of Human Physiology, University of Milano/Milano/Italie (1 aut.); Parkinson Institute, Istituti Clinici di Perfezionamento/Milano/Italie (1 aut., 4 aut., 8 aut., 9 aut., 11 aut.); Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico/Milano/Italie (2 aut., 5 aut.); Center for Neurosciences, The Feinstein Institute for Medical Research/Manhasset, New York/Etats-Unis (3 aut., 7 aut., 10 aut.); Neuroradiology Department, V. Buzzi Hospital/Milano/Italie (6 aut.); Departments of Neurology and Medicine, North Shore University Hospital, North Shore-LIJ Health System/Manhasset, New York/Etats-Unis (10 aut.); Institute of Neurology, IRCCS San Camillo, Venice and University of Padua/Italie (11 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 6; Pp. 679-686; Bibl. 44 ref.
LA : Anglais
EA : To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [99mTc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akineticrigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.
CC : 002B17; 002B24A06
FD : Tremblement; Pathologie du système nerveux; Tomoscintigraphie émission monophotonique; Photon
FG : Mouvement involontaire; Trouble neurologique
ED : Tremor; Nervous system diseases; Single photon emission tomography; Photon
EG : Involuntary movement; Neurological disorder
SD : Temblor; Sistema nervioso patología; Tomografía emisión fotón único; Fotón
LO : INIST-20953.354000181078480030
ID : 10-0233093

Links to Exploration step

Pascal:10-0233093

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Imaging Essential Tremor</title>
<author>
<name sortKey="Isaias, Ioannis U" sort="Isaias, Ioannis U" uniqKey="Isaias I" first="Ioannis U." last="Isaias">Ioannis U. Isaias</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Human Physiology, University of Milano</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Marotta, Giorgio" sort="Marotta, Giorgio" uniqKey="Marotta G" first="Giorgio" last="Marotta">Giorgio Marotta</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hirano, Shigeki" sort="Hirano, Shigeki" uniqKey="Hirano S" first="Shigeki" last="Hirano">Shigeki Hirano</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Canesi, Margherita" sort="Canesi, Margherita" uniqKey="Canesi M" first="Margherita" last="Canesi">Margherita Canesi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Benti, Riccardo" sort="Benti, Riccardo" uniqKey="Benti R" first="Riccardo" last="Benti">Riccardo Benti</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Righini, Andrea" sort="Righini, Andrea" uniqKey="Righini A" first="Andrea" last="Righini">Andrea Righini</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Neuroradiology Department, V. Buzzi Hospital</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chengke Tang" sort="Chengke Tang" uniqKey="Chengke Tang" last="Chengke Tang">CHENGKE TANG</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Cilia, Roberto" sort="Cilia, Roberto" uniqKey="Cilia R" first="Roberto" last="Cilia">Roberto Cilia</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pezzoli, Gianni" sort="Pezzoli, Gianni" uniqKey="Pezzoli G" first="Gianni" last="Pezzoli">Gianni Pezzoli</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="06">
<s1>Departments of Neurology and Medicine, North Shore University Hospital, North Shore-LIJ Health System</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="07">
<s1>Institute of Neurology, IRCCS San Camillo, Venice and University of Padua</s1>
<s3>ITA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0233093</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0233093 INIST</idno>
<idno type="RBID">Pascal:10-0233093</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B64</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Imaging Essential Tremor</title>
<author>
<name sortKey="Isaias, Ioannis U" sort="Isaias, Ioannis U" uniqKey="Isaias I" first="Ioannis U." last="Isaias">Ioannis U. Isaias</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Human Physiology, University of Milano</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Marotta, Giorgio" sort="Marotta, Giorgio" uniqKey="Marotta G" first="Giorgio" last="Marotta">Giorgio Marotta</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hirano, Shigeki" sort="Hirano, Shigeki" uniqKey="Hirano S" first="Shigeki" last="Hirano">Shigeki Hirano</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Canesi, Margherita" sort="Canesi, Margherita" uniqKey="Canesi M" first="Margherita" last="Canesi">Margherita Canesi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Benti, Riccardo" sort="Benti, Riccardo" uniqKey="Benti R" first="Riccardo" last="Benti">Riccardo Benti</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Righini, Andrea" sort="Righini, Andrea" uniqKey="Righini A" first="Andrea" last="Righini">Andrea Righini</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Neuroradiology Department, V. Buzzi Hospital</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chengke Tang" sort="Chengke Tang" uniqKey="Chengke Tang" last="Chengke Tang">CHENGKE TANG</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Cilia, Roberto" sort="Cilia, Roberto" uniqKey="Cilia R" first="Roberto" last="Cilia">Roberto Cilia</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pezzoli, Gianni" sort="Pezzoli, Gianni" uniqKey="Pezzoli G" first="Gianni" last="Pezzoli">Gianni Pezzoli</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="06">
<s1>Departments of Neurology and Medicine, North Shore University Hospital, North Shore-LIJ Health System</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="07">
<s1>Institute of Neurology, IRCCS San Camillo, Venice and University of Padua</s1>
<s3>ITA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Nervous system diseases</term>
<term>Photon</term>
<term>Single photon emission tomography</term>
<term>Tremor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Tremblement</term>
<term>Pathologie du système nerveux</term>
<term>Tomoscintigraphie émission monophotonique</term>
<term>Photon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [
<sup>99m</sup>
Tc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akineticrigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>25</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Imaging Essential Tremor</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ISAIAS (Ioannis U.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MAROTTA (Giorgio)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>HIRANO (Shigeki)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>CANESI (Margherita)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BENTI (Riccardo)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>RIGHINI (Andrea)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>CHENGKE TANG</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>CILIA (Roberto)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>PEZZOLI (Gianni)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>EIDELBERG (David)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>ANTONINI (Angelo)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Human Physiology, University of Milano</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Parkinson Institute, Istituti Clinici di Perfezionamento</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Center for Neurosciences, The Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Neuroradiology Department, V. Buzzi Hospital</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Departments of Neurology and Medicine, North Shore University Hospital, North Shore-LIJ Health System</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Institute of Neurology, IRCCS San Camillo, Venice and University of Padua</s1>
<s3>ITA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA20>
<s1>679-686</s1>
</fA20>
<fA21>
<s1>2010</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000181078480030</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>44 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>10-0233093</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [
<sup>99m</sup>
Tc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akineticrigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B24A06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Tremblement</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Tremor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Temblor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Tomoscintigraphie émission monophotonique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Single photon emission tomography</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Tomografía emisión fotón único</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Photon</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Photon</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Fotón</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fN21>
<s1>158</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 10-0233093 INIST</NO>
<ET>Imaging Essential Tremor</ET>
<AU>ISAIAS (Ioannis U.); MAROTTA (Giorgio); HIRANO (Shigeki); CANESI (Margherita); BENTI (Riccardo); RIGHINI (Andrea); CHENGKE TANG; CILIA (Roberto); PEZZOLI (Gianni); EIDELBERG (David); ANTONINI (Angelo)</AU>
<AF>Department of Human Physiology, University of Milano/Milano/Italie (1 aut.); Parkinson Institute, Istituti Clinici di Perfezionamento/Milano/Italie (1 aut., 4 aut., 8 aut., 9 aut., 11 aut.); Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico/Milano/Italie (2 aut., 5 aut.); Center for Neurosciences, The Feinstein Institute for Medical Research/Manhasset, New York/Etats-Unis (3 aut., 7 aut., 10 aut.); Neuroradiology Department, V. Buzzi Hospital/Milano/Italie (6 aut.); Departments of Neurology and Medicine, North Shore University Hospital, North Shore-LIJ Health System/Manhasset, New York/Etats-Unis (10 aut.); Institute of Neurology, IRCCS San Camillo, Venice and University of Padua/Italie (11 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 6; Pp. 679-686; Bibl. 44 ref.</SO>
<LA>Anglais</LA>
<EA>To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [
<sup>99m</sup>
Tc]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akineticrigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET.</EA>
<CC>002B17; 002B24A06</CC>
<FD>Tremblement; Pathologie du système nerveux; Tomoscintigraphie émission monophotonique; Photon</FD>
<FG>Mouvement involontaire; Trouble neurologique</FG>
<ED>Tremor; Nervous system diseases; Single photon emission tomography; Photon</ED>
<EG>Involuntary movement; Neurological disorder</EG>
<SD>Temblor; Sistema nervioso patología; Tomografía emisión fotón único; Fotón</SD>
<LO>INIST-20953.354000181078480030</LO>
<ID>10-0233093</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B64 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000B64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:10-0233093
   |texte=   Imaging Essential Tremor
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024